Polar Capital’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-100,000
| Closed | -$3.61M | – | 292 |
|
|
2018
Q4 | $3.61M | Sell |
100,000
-25,000
| -20% | -$903K | 0.04% | 221 |
|
|
2018
Q3 | $7.69M | Buy |
125,000
+50,000
| +67% | +$3.08M | 0.07% | 195 |
|
|
2018
Q2 | $5.07K | Buy |
75,000
+45,000
| +150% | +$3.04K | 0.03% | 222 |
|
|
2018
Q1 | $1.63M | Sell |
30,000
-70,000
| -70% | -$3.8M | 0.02% | 244 |
|
|
2017
Q4 | $5.98M | Buy |
+100,000
| New | +$5.98M | 0.06% | 190 |
|
|
2015
Q3 | – | Sell |
-36,130
| Closed | -$638K | – | 298 |
|
|
2015
Q2 | $638K | Buy |
36,130
+14,820
| +70% | +$262K | 0.01% | 262 |
|
|
2015
Q1 | $668K | Sell |
21,310
-4,097
| -16% | -$128K | 0.01% | 261 |
|
|
2014
Q4 | $742K | Buy |
25,407
+8,794
| +53% | +$257K | 0.01% | 245 |
|
|
2014
Q3 | $344K | Buy |
+16,613
| New | +$344K | 0.01% | 254 |
|